The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to ...

SK bioscience’s acquisition of German contract manufacturer IDT Biologika last year was a strategic play to globalize its ...

Experts have urged the Philippine government to expedite the approval of a new-generation of dengue vaccine, amid the rising ...

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a label narrower than initially targeted. The vaccine will be marketed ...

The US Food and Drug Administration has greenlit a next-generation COVID-19 vaccine from Moderna that’s engineered to be given in a smaller dose than the current one and targets certain portions ...